0.12%| Prev Close: | 1.26 |
|---|---|
| Open: | N/A |
| Bid: | 1.24 x 400 |
| Ask: | 1.25 x 2600 |
| 1y Target Est: | N/A |
| Beta: | 2.11 |
| Next Earnings Date: | N/A |
| Day's Range: | 1.23 - 1.28 |
|---|---|
| 52wk Range: | 1.01 - 2.94 |
| Volume: | 15,057 |
| Avg Vol (3m): | 197,283 |
| Market Cap: | 30.61M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.86 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Leading Independent Proxy Advisory Firms ISS and Glass, Lewis & Co., LLC Recommend Vote “FOR” BioSante/ANI MergerBusiness Wire(Mon Jun 10)
- BIOSANTE PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Tue May 21)
- BioSante Pharmaceuticals, Inc. Reports First Quarter Financial ResultsBusiness Wire(Fri May 10)
- BIOSANTE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online(Fri May 10)
- BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed MergerBusiness Wire(Wed May 8)
- Huge Potential But Tough Entry For Female Sexual Dysfunction Drugsat Seeking Alpha(Tue May 7)
- 4 Bio Stocks to Buy Todayat Motley Fool(Wed May 1)
- Ceregene Reports Data From Parkinson's Disease Phase 2b StudyPR Newswire(Fri Apr 19)
- BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce New Merger AgreementBusiness Wire(Fri Apr 12)
- BIOSANTE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a MateriaEDGAR Online(Fri Apr 12)
- Reviving The Blockbuster Potential Of Libigel For Biosante And Antares Pharmaat Seeking Alpha(Mon Apr 8)
- Antares: A Compelling Long Term Investmentat Seeking Alpha(Thu Mar 21)
- BioSante Pharmaceuticals, Inc. Sends Letter Urging Stockholders to Vote “FOR” Proposed Merger with ANI Pharmaceuticals, Inc.Business Wire(Tue Mar 19)
- BIOSANTE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters toEDGAR Online(Fri Mar 15)
- BioSante Pharmaceuticals Announces Adjournment of Its Stockholders Meeting Until April 12, 2013Business Wire(Fri Mar 15)
Press Releases
- Leading Independent Proxy Advisory Firms ISS and Glass, Lewis & Co., LLC Recommend Vote “FOR” BioSante/ANI MergerBusiness Wire(Mon Jun 10)
- BioSante Pharmaceuticals, Inc. Reports First Quarter Financial ResultsBusiness Wire(Fri May 10)
- BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed MergerBusiness Wire(Wed May 8)
Must Read
- Fed seen keeping options open on pace of bond buyingReuters(Wed 5:01AM EDT)
- RBC takes more optimistic view of Canadian economy, raises growth forecastThe Canadian Press(Wed 4:48AM EDT)
- Canada net foreign debt drops almost 25 percent in first quarterReuters(Wed 4:42AM EDT)
- Leaders downplay reports of stalled Canada-EU trade talksCBC(Wed 3:35AM EDT)
- How open is Ottawa's new 'open data' website?CBC(Wed 2:27AM EDT)